OCEANIT LABORATORIES INC — Department of Defense SBIR Phase II: DLA202-D013
OCEANIT LABORATORIES INC — SBIR Phase II award from Department of Defense.
- Amount
- $1,000,000
- Agency
- Department of Defense · Defense Logistics Agency
- Program / Phase
- SBIR · Phase II
- Topic
- DLA202-D013
- Solicitation
- 20.2
- NAICS
- —
- Place of performance
- HI
- Period
- 2021-02-01 → 2022-01-30
Description
Oceanit proposes to develop novel approach for the detection of and protection from emerging viral pandemic pathogens. Oceanit has previously developed novel binding molecules that successful target and bind to SARS-CoV-2 viral proteins and can be incorporated into detection products and surface prophylactic treatments. In this Direct to Phase II effort, Oceanit proposes to further develop the rapid development platform for use in current and future viral threats. The resulting products will be easy to use with minimal burden on logistics to effectively preven escalation of the transmission of viral pathogens.